Shielding One Memory Area During Whole-Brain Radiation
Original title: Unilateral vs Bilateral Hippocampal Avoidance During WBRT With Memantine for Brain Metastases: A Randomized Single-Blind Phase 2 Clinical Trial.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This was a small, early trial in people, and it still needs larger studies.
The short version
Shielding just the left memory area worked about as well as shielding both sides.
What was studied. Doctors studied 73 people with cancer that had spread to the brain. All got whole-brain radiation: Radiation given to the whole brain, rather than aimed at one spot. It is used when there are too many tumors to aim at one at a time. See the glossary and a drug called memantine: A medicine given with whole-brain radiation to help protect thinking and memory. See the glossary. For 36 people, only the left memory area was shielded. For 37 people, both memory areas were shielded.
What they found. Memory scores fell 4.75% in the one-side group and 5.05% in the both-sides group. That gap was small enough to count as equal under the study's rules. Side effects, the time before the cancer grew again, and how long people lived looked similar in both groups.
What this means, and what it doesn't
What it could mean: Shielding both memory areas is not always easy to do. If it is hard, shielding only the left side may be a fair option. This gives doctors something else to consider.
What it doesn't mean: This does not mean memory is kept safe. People in both groups still lost some memory. This was one small, early trial in 73 people. The researchers say it needs to be checked in more studies. One kind of memory was not tested at all. It is not a cure, and it does not change everyday care right now.
Source: PubMed, October 16, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.